Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Detects Tumor Markers Using Laser-Stimulated Fluorescence

By LabMedica International staff writers
Posted on 09 Apr 2014
Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously involving highly specific proteins.

An increased concentration in the blood provides one indication of the disease for physicians, but it has been quite expensive in time and effort to detect the markers thus far and to be able to detect a single specific one, scientists must first separate and purify the blood in several steps and then isolate the marker.

Scientists at the Fraunhofer Institute for Manufacturing Engineering and Automation IPA (Mannheim, Germany) have developed a one-step analysis to detect tumor biomarkers. More...
The difficulty in detecting specific molecules in the blood or urine lies in the enormous number of substances that are mixed in the sample. They cause a high level of background noise that masks the desired signal and the signal from the protein being searched for can no longer be distinguished.

To improve the signal to noise ratio, the scientists used magnetic beads, which are particles only a few micrometers in size that have a magnetic core. If a magnet is positioned externally on the test tube, the beads can be arrested or steered. This technique is already in use. To isolate molecules from a solution like blood, the surface of the beads with were coated with specialized antibodies. The proteins that are being searched for wind past the beads, and the antibodies attach to them. If the magnet is held to the outside of the test tube, the beads together with the desired proteins stick to the interior surface of the tube, while the rest of the solution can be easily removed.

Additional means were developed with the samples exposed to the coated beads, but also to additional antibodies that have fluorescent markers bound to them. These antibodies attach themselves to the proteins being searched for and cause them to fluoresce. The optical signal is very weak though, and would normally disappear in the background noise. When using an alternating magnetic field, the magnetic beads flock together in rhythm, and the fluorescent markers bound to the surfaces emit their light in synchrony and radiate considerably more brightly than any given bead by itself. The advantage of this visualization technique is that the optical signal provides immediate insight about whether a tumor marker protein is present in the blood. The analysis equipment was presented at the Analytica international trade fair held April 1–4, 2014, in Munich (Germany).

Related Links:

Fraunhofer Institute for Manufacturing Engineering and Automation



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.